Bernstein, Jonathan A., M.D. Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00406094
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

montelukast (singulair) (1 trial)

Drugs in Phase 2 Trials (1)

ecallantide (Kalbitor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angioedema (Phase 2)

Common Cold (Phase 4)

Rhinitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2